晚期卵巢癌间歇性减瘤术前CT淋巴结10mm截断值的预测价值
本研究回顾性纳入2005至2018年接受新辅助化疗后间歇性减瘤术及淋巴结清扫的158例卵巢癌患者,评估化疗前和化疗后CT以淋巴结短轴≥10mm为阳性预测组织学淋巴结受累的效能。结果显示CT预测敏感性低(化疗前35%、化疗后20%),特异性较高(化疗后97%),阳性患者2年无复发生存和5年总生存无显著降低。
要点
- CT淋巴结短轴≥10mm预测淋巴结受累敏感性低,化疗前35%、化疗后20%。
- 化疗后CT特异性达97%,阳性预测值91%,但阴性预测值仅47%。
- CT阳性淋巴结与2年无复发生存和5年总生存降低无显著相关。
核心结论
- CT上淋巴结增大是晚期卵巢癌新辅助化疗后淋巴结受累的弱预测指标,但可用于评估预后。
研究设计与样本
- 回顾性单中心队列研究,纳入2005至2018年接受新辅助化疗、间歇性减瘤术及淋巴结清扫的158例卵巢癌患者。
主要发现
- 158例中92例(58%)组织学淋巴结阳性。
- 化疗前CT敏感性35%、特异性82%、阴性预测值47%、阳性预测值73%。
- 化疗后CT敏感性20%、特异性97%、阴性预测值47%、阳性预测值91%。
- 化疗前或化疗后CT阳性患者2年无复发生存和5年总生存无显著降低。
- 化疗后仍阳性或转阳性(高风险)患者2年无复发生存和5年总生存无显著降低。
关键数值与推荐
- CT淋巴结短轴≥10mm定义为阳性。
临床怎么用
- CT淋巴结增大不应单独作为淋巴结清扫的决策依据,但阳性发现可辅助预后评估。
局限性
- 回顾性单中心设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The benefit of a systematic lymphadenectomy is still debated in patients undergoing neoadjuvant chemotherapy (NACT) followed by interval debulking surgery (IDS) in ovarian cancer (OC). The objective of this study was to evaluate the predictive value of the pre-NACT and post-NACT CT in predicting definitive histological lymph node involvement. The prognostic value of a positive node on the CT was also assessed. MATERIEL AND METHODS: A retrospective, unicentric cohort study was performed including all patients with ovarian cancer who underwent NACT and IDS with a lymphadenectomy between 2005 and 2018. CT were analyzed blinded to pathology, and nodes with small axis ≥ 10 mm on CT were considered positive. Sensitivity (Se), specificity (Sp), and negative (NPV) and positive predictive values (PPV) and their CI95% were calculated. The 2-year recurrence free survival (RFS) and 5-year overall survival (OS) was compared. RESULTS: 158 patients were included, among which 92 (58%) had histologically positive lymph nodes. CT had a Se, Sp, NPV and PPV of 35%, 82%, 47% and 73% before NACT and 20%, 97%, 47% and 91% after NACT, respectively. Patients with nodes considered positive had a non-significant lower 2-year RFS and 5-year OS on the pre-NACT and post-NACT CT. Patients at 'high risk' (nodes stayed positive on the CT or became positive after NACT) also had a non-significant lower 2-year RFS and 5-year OS. CONCLUSION: Presence of enlarged lymph nodes on CT is a weak indicator of lymph node involvement in patients with advanced ovarian cancer undergoing NACT. However, it could be used to assess prognosis.
引用
- Benoit L, Zerbib J, Koual M, et al. What can we learn from the 10 mm lymph node size cut-off on the CT in advanced ovarian cancer at the time of interval debulking surgery? Gynecol Oncol. 2021. PMID: 34217542. doi:10.1016/j.ygyno.2021.06.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。